We describe an extension of semiconductor fabrication methods that creates individual » 200 mm diameter aqueous pathways through human stratum corneum at predetermined sites. Our hypothesis is that spatially localized electroporation of the multilamellar lipid bilayer membranes provides rapid delivery of salicylic acid to the keratin within corneocytes, leading to localized keratin disruption and then to a microconduit. A microconduit penetrating the isolated stratum corneum supports a volumetric¯ow of order 0.01 ml per s with a pressure difference of only 0.01 atm (about 10 2 Pa). This study provides a method for rapidly microengineering a pathway in the skin to interface future devices for transdermal drug delivery and sampling of biologically relevant¯uids. Key words: keratolytic agents/skin electroporation/stratum corneum/transdermal drug delivery. J Invest Dermatol 116: 40±49, 2001 D rug delivery continues to be of great and growing interest (Langer, 1998) . Established delivery methods involving oral and injectable routes encounter signi®cant problems, such as high ®rst-pass hepatic metabolism and patient compliance. Minimally invasive transdermal intervention can avoid these problems and is increasingly viewed as an attractive alternative
D
rug delivery continues to be of great and growing interest (Langer, 1998) . Established delivery methods involving oral and injectable routes encounter signi®cant problems, such as high ®rst-pass hepatic metabolism and patient compliance. Minimally invasive transdermal intervention can avoid these problems and is increasingly viewed as an attractive alternative (Smith and Maibach, 1995; Guy, 1996; Schaefer and Redelmeier, 1996; Merino et al, 1997) . Analyte extraction through the skin is also being considered as a mean for analyte sampling (Tamada et al, 1995; Smith et al, 1999; Kost et al, 2000) . Transdermal molecular transport with temporal control would be valuable for both drug delivery and analyte sensing; however, the practical handling and obtrusiveness of present invasive transdermal delivery systems severely restrict their use in many day to day applications (Wouters and Dinh, 1997) . Miniature devices that interface with the skin over a microscopic area would offer a desirable alternative for transdermal drug delivery and sampling. The stratum corneum (SC) of the skin, the main barrier to transdermal delivery, limits the transport to clinically insuf®cient rates for most biologically active macromolecules, such as insulin or heparin. In this study, we describe an electrochemical method to create a microconduit (a microscopic aqueous pathway extending through the thickness of the SC) in the skin that should facilitate an unhindered transport across the skin of any macromolecule.
Several types of physical interventions using ultrasound, laser, high pressure, and microfabrication have been attempted for altering the SC. Low-frequency ultrasound was shown to increase the permeability of human skin by several orders of magnitude to many drugs, including high molecular weight proteins (Mitragotri et al, 1995; Kost et al, 2000) . Application of 168 kHz continuous ultrasound of spatially averaged pressure amplitude of 1.9 Q 10 5 Pa generated defects in human SC specimens (Wu et al, 1998) . A midinfrared Er:YSGG laser was used to ablate cadaveric swine SC leading to an increased permeability for H-3-hydrocortisone (Nelson et al, 1991) . A stress pulse generated by a single laser pulse was shown to increase transiently the permeability of the SC in vivo with recovery occurring within minutes (Lee et al, 1998) . A device that uses compressed helium gas to accelerate microscopic particles into the skin was used as a delivery system for DNA vaccines to elicit a virus-speci®c response in mice (Degano et al, 1998) . Siliconprocessed microneedles have been shown to increase permeability of human skin in vitro (Henry et al, 1998; Lin and Pisano, 1999 ). Altea's MicroPor uses thermal energy to vaporize the top layer of the epidermis within a small, sharply de®ned region to deliver drugs and sample interstitial¯uid (Smith et al, 1999) . Skin electroporation by high voltage pulsing provides an alternative method for transdermal drug delivery and analyte sampling. In this study, we report the creation of a microconduit at a known site in the SC by high-voltage pulsing in the presence of a keratolytic agent.
Skin electroporation is an extension of lipid bilayer membrane electroporation (Weaver and Chizmadzhev, 1996) , in which a brief elevation of the transmembrane voltage is hypothesized to create aqueous pathways (Fig 1, center) across the multilamellar bilayer membranes of the SC (Weaver et al, 1999a,b) . Based on the idea that electroporation could introduce low-toxicity keratolytic molecules into the corneocytes through these aqueous pathways, a hypothesis to create microconduits across SC was developed earlier (Ilic et al, 1999; Weaver et al, 1999b; Zewert et al, 1999) . The combination of new aqueous pathways through the multilamellar lipid bilayer membranes and disruption of the keratin matrix could result in dislodgement of entire stacks of corneocytes (Fig 1, right) , creating a minimum size (» 50 mm diameter) microconduit through the SC. Such an opening would present negligible steric hindrance to macromolecule transport. By using temporally controlled pressure-driven¯ow, large rates of molecular transport should be achieved, for both conventional pharmaceuticals and the larger peptides, proteins, and nucleotides from biotechnology.
Initial experiments (Zewert et al, 1999) using sodium thiosulfate (STS) as the keratolytic agent showed that a macromolecule (lactalbumin, » 15,000 g per mol) and smaller, charged molecule (sulforhodamine, 600 g per mol) were transported at almost the same rate across heat-stripped human skin in vitro; however, a large variability in microconduit creation was observed. In a subsequent study, urea was added to stabilize the STS-reduced (broken) disul®de bridges reduced, preventing them from reforming by oxidation (Ilic et al, 1999) . It was shown that » 1200 mm 2 diameter microconduit spanning the SC was created following treatment with STS and urea. The microconduit was shown to support volumetric¯ow of order 0.01 ml per s by a pressure difference of only 0.01 atm (about 10 2 Pa), demonstrating that the SC barrier had been completely removed within this microscopic area. Other studies showed that electroporation could be constrained to occur at predetermined sites (microholes in an insulating thin sheet) even with imperfect skin contact .
In this study, we investigate the use of active ingredients of Whit®eld's solution in creating a microconduit in human skin in vitro. Whit®eld's solution, with established keratolytic properties, ®nds extensive use in the topical treatment of intractable, super®cial (limited to the SC) dermatophyte infections of the skin (Holti, 1970; Clayton and Connor, 1973; Wright and Robertson, 1986; Russell and Russell, 1992; Gooskens et al, 1994; Diehl, 1996; Bennett, 1998 ). Whit®eld's solution achieves chemical decomposition of keratin by breaking the keratin peptide bonds and by reducing the binding forces within the SC, which is likely the basis for its keratolytic mode of action (Huber and Christopher, 1977; Gloor and Beier, 1984; Nook, 1987; Neubert et al, 1990; Lo Âden et al, 1995; Budavari, 1996; Lin and Nakatsui, 1998) . In this study we report a rapid, controlled method for creating a microconduit at a predetermined site in full-thickness human skin, with the microconduit supporting a pressure-driven¯ow across isolated SC.
MATERIALS AND METHODS
Microconduit creation procedure This in vitro study involves the investigation and partial optimization of an electrochemical process for microconduit creation. The two-step procedure involves: 1 Introduction of keratolytic chemicals into corneocytes at a predetermined microscopic area site by high-voltage pulsing that electroporates the multilamellar bilayer lipid membranes . This involves creation of many primary pores (diameter » 1 nm) within a spatially constrained local transport region by using an electrically insulating mask with a single » 200 mm microhole that spatially constrains the current; and 2 Rapid disruption of the keratin matrix within the electroporated corneocytes by the keratolytic solution.
Skin preparation Adult human skin was secured from the abdomen, arm, or back of cadavers (NDRI, Philadelphia, PA and Ohio Valley Tissue and Skin Center, Cincinnati, OH). The skin, stored at ±70°C, was cut into 1 inch (2.54 cm) square pieces and thawed to room temperature prior to the start of the experiment. The microconduit creation step was carried out using full thickness skin. The¯ow test (see section on tests for microconduit presence below) was carried out on thinned skin, prepared by heat stripping and/or treated with trypsin.
Heat stripping yields a specimen of thickness 100 T 50 mm. This procedure involves a well established method of immersing the skin in » 60°C water for 2 min (Gummer, 1989) . In some cases, overnight removal of the remaining epithelium was achieved by enzymatic trypsin digestion (Anderson et al, 1988) . The heat-stripped skin was digested in 1% trypsin (Sigma, St Louis, MO, T-0134) for 12 h at 4°C.
Experimental chambers Both high-voltage pulsing during the microconduit creation phase and iontophoresis thereafter, were carried out in the top±bottom chamber of Fig 2. The chamber is a modi®ed version of the side-by-side chamber in which the donor compartment is masked by a nonconducting polyimide sheet with an approximately 200 nm diameter microhole. A full-thickness skin specimen was mounted between the two compartments with the SC facing the donor and contacting the polyimide sheet. The¯ow test following the creation of a microconduit (after the skin was thinned) was performed in the side-byside chamber of Fig 3. Electrical pulsing In this study, the total time of the experiment, t total , the interval between pulses, t int , the high-voltage pulse decay constant, t pulse , and the peak current, I, were selected to deliver a total charge of about 40 mC during the pulsing protocol. The voltage across the skin, U skin , and the total charge transferred, q, were calculated according to Eq 1, and Eq 2, respectively.
where R PBS is the resistance of the phosphate-buffered saline (PBS) column between the measuring electrodes (Fig 2) with no skin present in the chamber. The peak voltage across the measuring electrodes, U inner , and the peak current, I, were measured from the exponential waveforms recorded during high-voltage pulsing. For a measured peak current, I, the total number of coulombs, q, transferred over the total time is: Figure 1 . Illustration of the hypothesis of microconduit creation using a modi®ed``brick wall model'' for human SC. (Weaver et al, 1997 A single local transport region is depicted, showing only about one-third of the 15±16 corneocyte layers of the SC. For simplicity, ordered stacks (columns) of corneocytes (Menton, 1976) are shown. Similar behavior is expected with disordered (offset) columns (Bergstresser and Chapman, 1980) , because typical corneocyte offsets introduce additional tortuosity that is about the same as the slight internal tortuosity expected within an ordered stack. Some of the pathways created by pulsing alone are hypothesized to be larger than pathways through the unperturbed keratin matrix (Zewert et al, 1995) . Left: Site prior to aqueous pathway creation. Left center: Site after several high-voltage pulses, depicting a high area density of straight-through primary pathways within the local transport region before enlargement by introduction of keratolytic molecules. Right: Microconduit resulting from removal of most of a weakened stack of corneocytes after keratin matrix disruption.
Figure 2. Chamber and circuitry used for electrochemical intervention. Both pulsing and measuring electrodes were made of stainless steel and were 3 cm long. The full-thickness skin was mounted with the SC contacting the 50 mm thick polyimide sheet containing a 200 mm diameter microhole. The current through the skin was determined from the voltage across the 2 W resistor. In all the experiments, the receptor compartment contained PBS (pH 7.4). High-voltage pulses were applied using an exponential pulser (Electroporation System 600, BTX Industries, San Diego, CA). A noninductive, high power rating (25 W) resistor (R meas = 2W) was placed in series with the chamber in order to measure the current through the skin. The measuring electrodes consisted of stainless steel wires (0.7 mm diameter, 3 cm long) placed in the inner ports of the chamber parallel to skin surface, at a distance of 1.5 cm between them (Fig 2) . The voltages across the inner electrodes (U inner ) and the 2 W series resistor during pulses (U meas = IR meas ) were stored in a digital oscilloscope (Hewlett Packard 54601) for determining U skin according to Eq 1.
Keratolytic molecules
In this study, we used skin electroporation with a topically applied solution of keratolytic molecules: salicylic acid (Sigma, S-0875, 138 g per mol) and benzoic acid (Sigma, B-3250, 122 g per mol).
In most experiments, 3% salicylic acid and 6% benzoic acid were used in a 70% ethanol and 30% PBS (pH 7.4) solution. These chemicals, in the concentrations mentioned above, form the active ingredients of Whit®eld's solution, which is a well-established topical medication with keratolytic activity.
Fluorescent molecules Sulforhodamine (Sigma; 607 g per mol; z = ±1;`r ed¯uorescence''; 0.5 mM in donor compartment) was used as ā uorescent tracer, because it is both water soluble and suf®ciently lipophylic that it also stains cell membranes (Chen et al, 1998) , allowing tissue accessed by the microconduit to be stained. The sulforhodamine molecule size is about 1.5 nm, which allows it to be readily transported through the primary aqueous pathways (about 2 nm diameter) created by high-voltage pulsing, and to pass with negligible steric hindrance through the intact keratin matrix within corneocytes.
A 2.5% volume suspension of¯uorescent latex beads (Fluoresbrite,`g reen¯uorescence''; Polysciences, Warrington, PA; 1.5 mm diameter) with a large negative charge (» ±8 Q 10 ±12 C) was used. These microbeads are much larger than typical macromolecules, and can often be detected individually by¯uorescence microscopy. Such beads do not penetrate the skin due to high-voltage pulsing alone (Chen et al, 1999) , owing to both their large charge and size.
Positive control To assess microconduit creation, electrochemically treated full thickness skin specimens were ®rst evaluated by four indicators that were established in positive control experiments. In these experiments, an approximately 200 mm diameter shallow microhole was drilled through the SC of a full thickness skin specimen by a cobalt microprecision drill bit (Gu Èhring, Brook®eld, WI). The skin specimen was then subjected to iontophoresis with PBS containing¯uorescent markers in the donor side (contacting the SC). The rationale was that a small, constant current preferentially transports these negatively charged markers into the low resistance microhole, thereby marking it for optical microscopy.
Negative control Negative control experiments were performed on unperturbed full thickness skin. The skin specimen was mounted in the top±bottom chamber (Fig 2) with the donor compartment containinḡ uorescent markers in PBS. The skin was subjected to iontophoresis with the same electrical parameters as in an actual experiment involving electrochemical treatment.
Iontophoresis control Iontophoresis control experiments refer to direct (low-voltage) current treatment of full thickness skin in the presence of keratolytic molecules. The skin specimen was mounted in the top±bottom chamber (Fig 2) with the donor compartment containing 3% salicylic acid and 6% benzoic acid in 70% ethanol and 30% PBS solution. The skin was subjected to 1 mA per cm 2 (over the area of a microhole in the insulating sheet, i.e., J = I/A mhole ) iontophoresis for 1 h. Following the treatment, the donor solution was replaced with the¯uorescent marker solution and the iontophoresis procedure was repeated for 1 h.
Pulsing control Pulsing control experiments relate to the electrical treatment of the skin without the use of keratolytic molecules. The skin was mounted in the top±bottom chamber (Fig 2) with the donor compartment containing PBS only, or 70% ethanol and 30% PBS. The skin was subjected to high-voltage pulsing and iontophoresis in the presence of¯uorescent markers with the same electrical parameters as in an actual experiment involving electrochemical treatment with keratolytic molecules. Note that because the PBS solution has a lower electrical resistance than the 70% ethanol + 30% aqueous solution, a larger fraction of the applied voltage appears across the skin. The importance of this``variable voltage divider'' effect is discussed elsewhere Pliquett 1999; Pliquett et al, 2000) .
Experimental procedure The experimental procedure involved in the electrochemical creation of a microconduit and in the tests to con®rm its presence is described below. 1 A previously thawed full-thickness human cadaver skin specimen was mounted in the top±bottom chamber (Fig 2) , avoiding visible skin deformation by excessive pressure. The integrity of the skin was evaluated by measuring the initial skin electrical resistance between the pulsing electrodes. 2 In positive control experiments, a 200 mm microhole, approximately 40 T 20 mm deep, was drilled in the skin. In negative control experiments, the skin was left unperturbed. In microconduit creation experiments, the donor compartment was ®lled with the keratolytic solution and the highvoltage pulsing protocol followed. 3 In order to transport negatively charged¯uorescent markers electrically, 1 h of 1 mA per cm 2 iontophoresis was applied (over the region of the skin exposed to the microhole in the insulating sheet) with the donor containing the two¯uorescent markers in PBS. The ®nal skin resistance was measured following iontophoresis. 4 The skin was then examined by optical microscopy using both incandescent and¯uorescent illumination. Further imaging and¯ow tests were performed after the skin was heat stripped, and in some cases, further treated with trypsin. Thus thinned skin was mounted in the side-by-side chamber (Fig 3) with a column of aqueous solution on the donor side. Thē ow was recorded at various time intervals as the decrease in the column level.
Tests for microconduit presence The creation of a microconduit was assessed using three independent tests: the resistance ratio test, the imaging tests, and the pressure-driven volumetric¯ow test. The ®rst test was applied to full-thickness skin, the last test was applied after the skin was thinned by heat stripping (Gummer, 1989) or heat stripping and enzymatic (trypsin) digestion of the epidermis, the combination yielding isolated SC (Anderson et al, 1988) . The second test was applied to both full-thickness and thinned skin specimens.
Resistance ratio test High-voltage pulsing and the use of keratolytic molecules create SC spanning aqueous pathways in the skin. This change in skin structure is re¯ected partially by a change in skin resistance. An LCR meter (SR715, Stanford Research Systems, Sunnyvale, CA) was used to measure the real part of the low frequency skin impedance (100 mV, 100 Hz sinusoidal input). A parallel RC model was assumed for the skin. Because the capacitance of the skin changes very little following highvoltage pulsing, the transdermal resistance, R skin , dominates the skin impedance. The decrease in R skin following treatment was quanti®ed by the resistance ratio f R , de®ned as
Figure 3. Chamber used in¯ow experiments. The electrochemically treated skin, after thinning by either heat stripping and/or treatment with trypsin, was mounted in the chamber with the SC facing the donor compartment. A column of aqueous solution was added to the donor compartment in order to establish a hydrostatic pressure difference across the skin. The presence of a microconduit in the skin resulted in a continuous decrease in the level of the aqueous column. The column height, h, was recorded at a number of time points and used in¯uid¯ow analysis to estimate the diameter of the microconduit.
where R i skin and R f skin are the initial and ®nal skin resistances, measured before and after the treatment, respectively. The resistances were corrected for a baseline resistance that accounted for the resistance of the PBS between the measuring electrodes and the resistance of the electrodes. The baseline resistance was measured at the end of each experiment with no skin present in the chamber. A large, persisting change in skin resistance was used as an indicator for the creation of a microconduit.
Imaging test To assess the creation of a microconduit, full-thickness skin specimens were ®rst evaluated by imaging using incandescent and uorescence microscopy. Then, imaging was repeated following heat stripping, and again following treatment with trypsin to con®rm the creation of a microconduit.
After the brief electrochemical procedure, the skin specimen was subjected to iontophoresis in the presence of PBS containing sulforhodamine and¯uorescent beads. The rationale is that a small, constant current preferentially drives these markers into the low resistance microconduit, thereby marking it identi®able by optical microscopy. On completion of high-voltage pulsing and iontophoresis, the skin was removed from the chamber and rinsed with de-ionized water. The skin was mounted on a microscope slide and examined under a¯uorescence microscope (Olympus BH-2, Olympus, Woodbury, NY). The¯uorescent image of the skin was acquired using a CCD camera (Pixera, Los Gatos, CA). Imaging was also carried out further at two stages: after heat stripping and (in some cases) after further treatment by enzymatic trypsin digestion. An incandescent (white) light source was placed below the specimen, with observation from above. As light passes through the microconduit, the opening in the skin appears as a single, bright spot surrounded by a dark region of intact skin.
Pressure-driven volumetric¯ow test The most direct, functional evidence for the presence of a microconduit is a measurable volumetric ow. Thus, a pressure driven¯ow across the electrochemically treated skin was used as a test for the presence of a microconduit. Either the heatstripped skin or the enzymatically isolated SC was mounted in the side-byside chamber (Fig 3) . Pressure-driven¯ow was then measured by establishing a hydrostatic pressure difference between the two compartments of the chamber, using a vertical column of up to 12 cm aqueous solution on the donor side. Volumetric¯ow was measured by recording the height of the solution column meniscus as a function of time, t, and multiplying by the cross-sectional area of the column to obtain the volume accumulation with time.
Well-established¯uid dynamics equations (White, 1979) were used to relate the diameter, D MC of the microconduit with the coef®cients obtained from the least square ®t of a polynomial a 1 t 2 + a 2 t to the experimental data points for the¯uid volume change with time, V(t). The microconduit diameter D MC was calculated assuming¯uid¯ow through an ori®ce as
Here, A col is the cross-sectional area of the column of aqueous solution, g = 9.8 m per s 2 is the local value of the earth's gravitational acceleration, and 0.6 is the aqueous solution coef®cient of velocity for a short tube approximation (White, 1979) , which is appropriate for a » 200 mm diameter microconduit with a thickness ranging from » 20 mm (isolated SC) to » 100 T 50 mm (heat-stripped skin).
RESULTS AND DISCUSSION
The motivation of this in vitro study is to investigate the ef®cacy of the ethanol, salicylic acid and benzoic acid solution in creating a microconduit in the SC of human skin. The presence of a microconduit was assessed using three independent tests. The results of these tests are summarized in Tables I and II , and Figs 4± 9. Based on positive control results, four features were identi®ed as indicators of the presence of a microconduit: 1 f R , the resistance ratio, which represents the change in skin resistance from the initial, unperturbed state to that following the electrochemical treatment. The presence of a microconduit causes a large increase in f R . 2 Macro Focus: macroscopic focusing, is the presence of a focused spot on the skin at the site where the microhole of the chamber contacted the skin, as seen in the macroscopic view of the skin. When a microconduit is created using the electrochemical treatment, sulforhodamine present in the donor solution enters the microconduit to form a red¯uorescent spot approximately equal in dimension to the microhole in the insulating sheet. 3 Micro Focus: microscopic focusing, is the presence of a focused cluster of negatively charged¯uorescent microbeads at the site of the microconduit. If a microconduit is created following the electrochemical treatment, iontophoresis of the skin with highly charged¯uorescent beads in the donor compartment causes the beads to be clustered in the microconduit. 4 Vert Pool: vertical pooling, denotes the pooling of the beads throughout the depth of the SC (» 20 mm) if a microconduit is created in the skin. The vertical pooling of¯uorescent beads is determined by acquiring¯uorescent images of the skin at various depths.
A large value of f R accompanied by the presence of the remaining three indicators strongly indicates the presence of a microconduit following the electrochemical procedure. The presence or absence of optical indicators is denoted by + or ±, respectively, in Table I .
Figures 4±8 display the results of different control and electrochemical treatment procedures on full-thickness human skin. The top left panel shows the macroscopic view of the skin. The top center and top right images are¯uorescent images of the skin at different depths (30 mm apart). The bottom panels show uorescent images of the skin at a higher magni®cation, acquired at different depths, 5 mm apart.
Negative controls Five negative control experiments were performed on unperturbed full-thickness skin exposed to either a Note that in all experiments, following either control exposure, mechanical microhole creation, or electrochemical intervention, the skin was subjected to 1 h iontophoresis at 1 mA per cm 2 (over the area of the microhole in the polyimide sheet) before indicators were ascertained. Four indicators were derived from resistance ratio and optical tests. These are denoted by f R (resistance ratio), Macro Focus (macroscopic focusing), Micro Focus (microscopic focusing), Vert Pool (vertical pooling), and are described in the text. Some of the results are accompanied by images indexed in the right-hand column.``²'' indicates the pulsing only controls (n = 5). Presence/absence of optical indicators are denoted by +/±.
PBS only or to 70% ethanol and 30% PBS. The skin was subjected to iontophoresis in the presence of the¯uorescent markers for the same duration as in an experiment with electrochemical treatment. The resistance ratio was 4 T 1 (PBS only) and 3 T 1 (70% ethanol and 30% PBS) following iontophoresis ( Table I) . Iontophoresis of unperturbed skin did not cause a focused clustering of beads at the site of the microhole and the beads did not persist throughout the depth of SC (Fig 4) , i.e., Micro Focus and Vert Pool were negative, respectively. The macroscopic view of the skin did not show a focused spot where the skin contacted the microhole in the polyimide sheet, when exposed to PBS only. When exposed to 70% ethanol, Macro Focus was positive, indicating minor perturbation of lipids of SC, allowing binding of sulforhodamine.
Iontophoresis controls Five iontophoresis control experiments
were performed on full-thickness skin exposed to 1 h of 1 mA per cm 2 iontophoresis in the presence of salicylic acid and benzoic acid. The resistance ratio following the treatment was 4 T 2 ( Table I ). The top center and top right images are¯uorescent images of the skin taken at different depths (30 mm apart). The bright spots, which represent uorescent beads, indicate only discrete binding of beads to the skin. There is no cluster of¯uores-cent beads present in the skin. The dark region represents staining of the skin by sulforhodamine. The bottom images are¯uorescent images of the skin at a higher magni®cation. The images are taken at different depths, 5 mm apart. The disjoint presence of beads is clearly visible suggesting that there is microconduit in the skin. a The skin in these experiments was heat stripped and/or treated with trypsin overnight following the electrochemical process of microconduit (MC) creation. The entries in this table are similar to those in Table I . Two de®nite con®rmations of a microconduit are listed here for each experiment. MC visualized relates to whether the MC was visualized by optical microscopy, either after heat stripping or treatment with trypsin. Fluid¯ow indicates whether a¯uid¯ow was observed in the pressure-driven uid¯ow test after treatment with trypsin. Presence/absence of de®nite con®rmations are denoted by +/±. Figure 4 . Negative control. A full thickness human skin was subjected only to iontophoresis for 1 h with sulforhodamine and¯uorescent beads suspended in saline in the donor compartment. Top left is the macroscopic view of the skin. The black ellipse encompasses the site of the polyimide microhole that contacted the skin. No extensive staining of the skin by sulforhodamine is evident. The top center and top right images are¯uorescent images of the skin taken at different depths (30 mm apart). The bright spots, which represent uorescent beads, indicate discrete binding of beads to the skin. There is no cluster of¯uores-cent beads present in the skin. The dark region represents staining of the skin by sulforhodamine. The bottom images are¯uorescent images of the skin at a higher magni®cation. The images are taken at different depths, 5 mm apart. The disjoint presence of beads is clearly visible. The beads do not persist over a large depth suggesting that there is no pathway spanning the SC in the skin.
Following the treatment, the skin was subjected to another 1 h of iontophoresis with the¯uorescent dye solution in the donor chamber. Iontophoresis of unperturbed skin did not cause a focused clustering of beads at the site of the microhole and the beads did not persist throughout the depth of SC (Fig 5) , i.e., Micro Focus and Vert Pool were negative, respectively; however, the macroscopic view of the skin showed a focused spot where the skin contacted the microhole in the polyimide sheet (Fig 5) . It is clear that iontophoresis treatment alone is not suf®cient to transport the keratolytic molecules into the corneocytes to create a microconduit in the skin.
Positive controls In ®ve positive control experiments, an approximately 200 mm diameter hole through the SC and about 40 T 20 mm deep was created by a cobalt microprecision drill bit in full-thickness human cadaver skin. The skin specimen was then subjected to iontophoresis with PBS containing¯uorescent markers in the donor compartment (contacting the SC). Following the creation of a hole in the skin, f R was 16 T 2, indicating the presence of new aqueous pathways in the skin. In addition, all three optical indicators were present ( Table I) . A well-de®ned spot was visible in the skin, stained red (¯uorescence) by sulforhodamine in the donor solution (Fig 6, top left; this represents Macro Focus). Thē uorescence image of the skin also revealed a dense cluster of uorescent beads in the spot (Fig 6, top right; this represents Micro Focus). The cluster of beads persisted as the plane of view was moved deeper than 15 mm from the SC surface (Fig 6, bottom; this represents Vert Pool). The small, constant iontophoresis current preferentially had driven the beads into the low resistance microhole. Pulsing control Two types of pulsing controls were performed. In the ®rst case, the donor compartment contained PBS whereas in the second case, the donor compartment contained 70% ethanol in PBS. In both cases, the skin was subjected to high-voltage pulsing and iontophoresis, but without any keratolytic molecules in the donor solution.
When the skin was pulsed in the presence of PBS, with 40 mC of charge delivered, the resistance ratio increased to 6, similar to an increase to 4 in the negative control experiments ( Table I) . As in the negative control experiments, all three optical indicators were negative. The¯uorescence image of the skin showed no areas with clustered beads, only scattered beads were visible (Fig 7) . These indicators suggest that high-voltage pulsing alone causes no disruption to the keratin matrix and therefore does not create a microconduit in the SC.
When the skin was pulsed in 70% ethanol, the resistance ratio increased to 10 T 1 when the total charge delivered was 36 mC. The macroscopic view of the skin showed a focused red spot at the site of the microhole. The other two¯uorescent indicators were negative. The presence of ethanol during high-voltage pulsing only marginally increased the permeability of SC and thus the appearance of a sulforhodamine-stained spot on the skin due to increased access to lipids. (Table I , third row) with only PBS and¯uorescent markers in the donor compartment during high-voltage pulsing and iontophoresis, respectively. Top left image (macroscopic view) shows no focused red spot. The low-magni®cation¯uorescent images (top center and top right; 30 mm apart in depth) show no areas with large density of¯uorescent beads. Similarly, the magni®ed¯uorescent images (bottom panel, 5 mm apart in depth) show only a scattered, distribution of uorescent beads. These images suggest that there was no extensive keratin disruption following high-voltage pulsing when keratolytic agents were absent during high-voltage pulsing. Figure 6 . Positive control. A shallow » 200 mm hole was drilled into the full-thickness skin using a cobalt microprecision drill. The skin was then subjected to iontophoresis for 1 h in the presence of sulforhodamine and latex beads suspended in PBS in the donor compartment. The top left image shows the macroscopic view of the image following iontophoresis. A focused red (here dark) spot (denoted Macro Focus in Table I ) is seen (arrow) at the site where the skin came into contact with the microhole in the chamber. Top center and top right images are¯uorescent images of the skin, imaged 20 mm apart in depth. The images show a dense cluster of¯uorescent beads at the site of the microhole (denoted Micro Focus in Table I ). Images in the bottom panel show the¯uorescent images at a higher magni®cation, separated by 15 mm in depth. The cluster of¯uorescent beads persists over more than 15 mm in depth (denoted Vert Pool in Table I ). Contrast to the negative control experiments, the beads are not distributed as individual beads, they are instead clustered within the microhole.
Electrochemical creation of a microconduit The main objective of this study is to characterize the use of high-voltage pulsing and two pathway-enlarging molecules to create a microconduit in human skin. The parameters of high-voltage pulsing and concentrations of the keratolytic chemicals were varied to optimize the process of microconduit creation.
Pulsing control experiments demonstrated that high-voltage pulsing alone does not disrupt the keratin matrix. Salicylic acid and benzoic acid are present in concentrations of 3% and 6% in Whit®eld's solution. Electrochemical treatment of full-thickness skin with 1/10th this concentration did not reveal the presence of a microconduit. Only one of three optical indicators was positive ( Table I) . Although the skin showed a macroscopic red spot indicating sulforhodamine staining of the ethanol altered lipids, no cluster of¯uorescent beads was found in the red spot. Following the treatment, f R increased to » 10 T 1, less than that observed in positive control experiments. This suggests that the concentrations of the keratolytic components were not high enough to cause an enlarged pathway in SC.
As a low concentration of keratolytic agents did not enlarge pathways created by high-voltage pulsing, the remaining experiments were conducted at concentrations present in Whit®eld's ointment. Thus, during the electrochemical intervention, the donor compartment contained 3% salicylic acid and 6% benzoic acid in 70% ethanol with two¯uorescent markers. The results of these experiments are tabulated in the last four rows of Table I .
Electrochemical treatment of full-thickness human skin with 3% salicylic acid and 6% benzoic acid consistently created a microconduit in SC. This was ascertained from resistance ratio and imaging tests. All three imaging indicators were positive in these experiments. The resistance ratio, following electrochemical intervention, ranged from 26 to 49 (Table I, last four rows). These values are higher than even that measured in positive control experiments. This strongly supports the presence of an enlarged aqueous pathway in the treated skin. Figure 8 shows the images of a full-thickness skin specimen following electrochemical treatment. In the macroscopic view (top left), a well-de®ned red spot is clearly seen at the site where the skin contacted the microhole in the polyimide sheet. The red spot Figure 9 . Visualization of a microconduit. A full-thickness skin was subjected to a 10 min electrochemical process (Table II) in the presence of sulforhodamine. Top left image shows the macroscopic view of the skin, with a focused red (here dark) spot formed by sulforhodamine staining of the microconduit (arrow). Top right is the corresponding¯uorescent image, which shows the presence of sulforhodamine in the microconduit (seen as dark regions in the gray-scale image). The skin was then heat stripped to get a thinned specimen. Bottom left shows the¯uorescent image of the heat-stripped skin. The central bright region is the region of the skin that contacted the microhole in the polyimide sheet. The bottom right is an incandescent image of the heat-stripped skin, illuminated from below using a bright light source. The microconduit in the skin (enclosed by the white circle) is brightly illuminated by light passing through the microconduit in the skin. This image provides the most striking optical evidence of the presence of a microconduit in the skin. Figure 8 . Electrochemical creation of a microconduit. A full-thickness skin specimen was subjected to a 10 min electrochemical treatment involving 3% salicylic acid and 6% benzoic acid in 70% ethanol and 30% PBS ( Table I) . The electrochemical protocol is followed by iontophoresis for 1 h at 1 mA per cm 2 in the presence of large latex beads and sulforhodamine. The macroscopic view of the skin (top left) shows a focused red spot at the site of microhole contact. The¯uorescent images (top center and top right; 20 mm apart in depth) show a dense cluster of uorescent beads. The¯uorescent images at higher magni®cation (bottom panel; 15 mm depth intervals) also show a cluster of beads that persist over 20 mm deep. These images relate to positive indicators, labeled Macro Focus, Micro Focus, and Vert Pool in Table I . The features in these images are essentially the same as those obtained in positive control experiments (Fig 5) . The results suggest that a SC-spanning microhole has been created in the full-thickness skin following electrochemical treatment.
results from the staining of sulforhodamine, which now ®nds access to corneocytes deeper into the skin (Macro Focus positive). Thē uorescence images of the skin (top center and top right) show a dense cluster of¯uorescent beads in the microconduit (Micro Focus positive). Iontophoresis following the microconduit creation phase of the protocol concentrates the charged beads at the site of the lowest resistance, i.e., the microconduit. The¯uorescence images of the skin at a higher magni®cation (bottom panels) show that the cluster of¯uorescent beads persists over 20 mm in depth from the surface of the SC (Vert Pool positive). This provides strong evidence that a microconduit has been created that spans the SC following treatment with the keratolytic chemicals.
Direct comparison of the results associated with an electrochemically created microconduit using indicators observed iǹ`p ositive controls'' were used to establish tentative conditions for microconduit creation; however, the degree of keratin disruption is not easily ascertained using these indicators. Hence in the next six experiments listed in Table II , the full-thickness skin was thinned after electrochemical treatment either by heat stripping alone or by treating the heat-stripped skin with trypsin. Imaging and¯ow tests on thinned skin provided con®rmatory evidence of the presence of a microconduit (Figs 9 and 10) .
In Fig 9 , the top panels (left and right) show macroscopic and microscopic views of the sulforhodamine-stained skin after the electrochemical protocol. The bottom images were acquired after skin thinning. The heat-stripped skin shows a red spot (the light gray region in Fig 9, bottom left) at the site of microhole indicating the sulforhodamine staining of the region exposed to the electrochemical treatment. When heat-stripped skin is exposed to incandescent light from below, a bright region is seen at the site of the microconduit (Fig 9, bottom right) . This provides a strong evidence that a microconduit spanning the SC has been created, which allows light to pass through.
More striking evidence of a microconduit is provided by thē ow tests on skin treated with trypsin following the electrochemical treatment. Treatment with trypsin leaves mostly the SC, therefore a microconduit spanning the SC should support a measurable¯ow. Pressure-driven¯ow was measured by establishing a small hydrostatic pressure difference between the two compartments of the chamber, using a vertical column of up to 12 cm aqueous solution on the donor side. Figure 10 shows the volume of solute transported through the microconduit as a function of time. The measured¯ow was compared with ®t to theoretical model (Eqn 4) to estimate the size of the microconduit. The best ®t estimate for the microconduit diameter of the specimen shown is 200 T 20 mm. This dimension, along with the resistance ratio values and other four indicators, is similar to that observed in positive control experiments.
The striking con®rmatory evidence for the presence of a microconduit was obtained from the volumetric¯ow test. Fluid ow was consistently observed in all six different electrochemical treatments (Table II) , even in the isolated SC cases where microconduit could not be directly visualized (microconduit visualized negative). The heat-stripping procedure leaves a variable number of epithelial layers attached to the SC, which prevents light from passing through a microconduit spanning only the SC. Treatment with trypsin removed the epithelium, leaving only the SC; however, the resulting preparation is too thin to provide an optical contrast between the microconduit and the rest of the intact SC. In such conditions, a microconduit is dif®cult to visualize directly. A pressure-driven¯ow alone provides reliable evidence for the presence of a microconduit. The¯ow test indicates that the electrochemical procedure used in this study creates microconduits in the range of 200 mm, which support¯uid transport in the order of 0.01 ml per s. (Zewert et al, 1999) using STS showed that a macromolecule (lactalbumin, » 15,000 g per mol) and » 1 mm charged beads were transported through microconduits in heat-stripped skin; however, a large variability in microconduit creation was observed in these experiments. A following study (Ilic et al, 1999) employed STS with urea to achieve a more controlled microconduit creation. The use of urea as an alkylating agent prevented the oxidation of disul®de bridges reduced by STS. In this study, another solution known for its keratolytic potential was used to create microconduits.
Keratolytic molecules Previous experiments
Both salicylic acid and benzoic acid are small, and are easily introduced into corneocytes by electroporation. high-voltage transdermal voltage pulses create new, small aqueous pathways (``pores'') in the multilamellar lipids of the SC, thereby providing salicylic acid and benzoic acid with entry points into corneocytes. During pulsing, these chemicals are electrically driven into corneocytes within a local transport region. Salicylic acid degrades the keratin within electroporated corneocytes, thereby greatly decreasing the steric hindrance over the localized area of the skin exposed to the chemicals and high-voltage pulses (Fig 1) . This results in a greatly enlarged aqueous pathway, namely, a microconduit spanning the SC. In this study, partially optimized protocol lasting about 5 min was needed to create a microconduit.
Salicylic acid is routinely used to degrade and extract keratin. Salicylic acid and benzoic acid, active ingredients of Whit®eld's solution, achieve the chemical decomposition of keratin by breaking the keratin peptide bonds and by reducing the binding forces within the SC and ®nd wide applications in treatment of skin ailments. In our protocol, the skin is exposed to a small amount of salicylic acid and benzoic acid over a microscopic region for less than 5 min. This level of exposure is considerably lower than that in established applications of Whit®eld's ointment. Hence, we expect no toxic effects to result from the electrochemical treatment reported here.
Localization of SC disruption An insulating sheet with a microhole was used in contact with the SC to limit the electrochemical intervention to a very small area of the skin. As shown previously, even without a perfect seal, such a masking causes localized electroporation at the microholes . Electrochemical treatment through a 200 mm microhole in the polyimide sheet was shown to create a 200 T 20 mm diameter microconduits spanning the SC. A simple extension of this result suggests that a reduction in the size of the masking microhole would result in a smaller microconduit. Figure 10 . Volume vs time due to pressure-driven volumetric¯ow through a microconduit. The heat-stripped skin of Fig 8 was treated with trypsin overnight to obtain an isolated SC preparation. The skin was mounted in the side-by-side chamber with a hydrostatic pressure column (Fig 2) . The pressure difference caused a¯ow through the microconduit in the skin. The decrease in the aqueous column height was recorded as a function of time (indicated by s and * for two independent data sets). A theoretical ®t to the¯ow data (Eq 4) is shown by the solid line, yielding a microconduit diameter of 200 T 20 mm.
Aqueous pathway creation time The protocol used in this study provides a reliable creation of a microconduit with a 10 min (t total = 600 s) electrochemical intervention; however, the cumulative electrical exposure is much shorter, less than 1 s. If only an electrical exposure in the presence of the keratolytic molecules is needed to create a microconduit, the present protocol might be shortened to a very rapid (less than 1 s) procedure; however, the role of the extra incubating period of the irreversible degradation of the keratin matrix is not yet established.
Microfabrication of transdermal aqueous pathways Miniature devices that interface with biologic systems over a microscopic area are being designed both for drug delivery and sensing. Systems based on gas generation by an electrolytic reaction (O'Keefe et al, 1994 ) and on a shape memory actuated microvalve system (Reynaerts et al, 1996) have been developed and tested for liquid drug delivery. A Microelectromechanical system for drug delivery using iontophoresis has been reported recently (Wouters and Dinh, 1997) . Of late, there has also been an increasing interest in¯ow type biosensing devices, which take up samples at a constant rate and perform an in situ or in vivo monitoring (Steenkiste et al, 1997) . Our study provides a method for rapidly microengineering a pathway in the skin to interface future devices for delivery and sampling of biologically relevant¯uids.
Localized physical perturbations One classic example is tracketched ®lter fabrication (Nucleopore), in which penetrating ionizing particles create a damage track through a polycarbonate thin sheet, followed by chemical etching along the damage track. Another is the widespread use of photolithography in semiconductor fabrication, where physical masks control which regions are exposed to various kinds of light, and after selected regions experience photodamage to material such as photoresist, a chemical etch removes material from targeted regions. We view the in situ creation of a microconduit as an analogous process: localized high-voltage pulsing creates localized aqueous pathways, through which keratolytic ions or molecules are introduced, leading to selective removal of material to create a microconduit. This analogy is illustrated in Fig 11. The creation of a SC-spanning microconduit that encompasses a microscopic area of the skin may enable the miniaturization of all the elements of a transdermal drug delivery system while providing an acceptable level of transport. A spatially localized intervention may lead to acceptable levels of sensation and unobtrusiveness, which are essential for the widespread application of a medical system. Figure 11 . Comparison of established and microconduit microfabrication methods. The common basic idea is that of a localized physical perturbation followed by chemical (keratolytic agent) disruption of a local region made accessible by the physical perturbation. Top: Creation of a track-etched ®lter (e.g., Nucleopore) by ionizing radiation and subsequent chemical etch. Center: Semiconductor photolithography using localized light exposure followed by chemical removal of exposed silicon regions. Bottom: Microconduit creation by localized SC electroporation followed by chemical disruption of the now accessible material (keratin matrix and apparently corneocyte envelopes) within corneocytes.
